AbbVie (ABBV) AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting

AbbVie (NYSE: ABBV) FY 2026 Other Release

Newsdesk: